ABNORMAL UTERINE BLEEDING Randomized Data Shed Light on AUB Associated with Fibroids, Adenomyosis, and the Use of Progestins

Total Page:16

File Type:pdf, Size:1020Kb

ABNORMAL UTERINE BLEEDING Randomized Data Shed Light on AUB Associated with Fibroids, Adenomyosis, and the Use of Progestins UPDATE ABNORMAL UTERINE BLEEDING Randomized data shed light on AUB associated with fibroids, adenomyosis, and the use of progestins ›› Malcolm G. Munro, MD Dr. Munro is Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA and Director of Gynecologic Services at Kaiser Permanente, Los Angeles Medical Center, in Los Angeles, California. Dr. Munro reports that he is a consultant to Bayer HealthCare. s recently defined by the International • Coagulopathy AFederation of Gynecology and Obstet- • Ovulatory disorders rics (FIGO)—and endorsed by the American • Endometrial dysfunction College of Obstetricians and Gynecologists— • Iatrogenic the term “abnormal uterine bleeding” (AUB) • Not otherwise classified. IN THIS ARTICLE now describes any departure from normal A given individual may be found to have one menstrual bleeding.1 To determine the most or more of these features, but not all of the Consider the appropriate intervention for this widespread features may contribute to the AUB. To facili- levonorgestrel- problem, FIGO proposed that clinicians con- tate their use, these nine causes are more releasing sider potential contributors to the clinical commonly identified using the acronym intrauterine system problem by investigating and categorizing PALM-COEIN. for AUB related to patients according to the following system: In this article, I focus on three of these adenomyosis • Polyp categories, presenting recent data on AUB • Adenomyosis associated with leiomyomata (AUB-L) or ade- page 30 • Leiomyoma nomyosis (AUB-A), and AUB of an iatrogenic • Malignancy and hyperplasia nature (AUB-I). For AUB associated with the use of progestins, concomitant AUB-L: Satisfaction rates are similar doxycycline may be of benefit 5 years after fibroid treatment by page 31 surgery or uterine artery embolization Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine omen who undergo uterine artery artery embolization for symptomatic uterine fibroids. Wembolization (UAE) for the treatment of Cochrane Database Syst Rev. 2012;5:CD005073. symptomatic uterine fibroids are just as satis- doi:10.1002/14651858.CD005073.pub3. fied with the outcome as women treated with hysterectomy or myomectomy, according to obgmanagement.com Vol. 26 No. 3 | March 2014 | OBG Management 27 UPDATE abnormal uterine bleeding this 2012 review from the Cochrane Database. WHAT THIS EVIDENCE MEANS Gupta and colleagues found similar FOR PRACTICE patient-satisfaction rates at 5 years (odds ratio [OR] 0.9; 95% confidence interval [CI], This review demonstrates that women are 0.45–1.8), although women undergoing UAE satisfied with outcomes five years after were more likely to require additional inter- UAE and that ovarian failure is not more ventions within 2 years (56 additional inter- common after UAE than after surgery. ventions per 1,000 women for surgery vs Although the available evidence dem- 250 per 1,000 women for UAE; OR, 5.64). onstrates that pregnancy following UAE is possible, women requiring a surgical procedure for AUB-L who are uncertain Details and general findings about their childbearing plans or who are Gupta and colleagues selected randomized, hoping to conceive should be encouraged controlled trials comparing UAE with surgery: to select myomectomy as their interven- • three trials of UAE versus abdominal hys- tion of choice. terectomy (n = 291) • one trial of UAE versus hysterectomy or myomectomy (the specific surgery was • Pregnancy was less likely after UAE determined by patient preference) (n = 157) than after myomectomy. In the trial • one trial of UAE versus myomectomy comparing UAE with myomectomy, in women desiring future childbearing 26 women later tried to conceive after UAE (n = 121). versus 40 after myomectomy. Significantly In these trials, UAE was bilateral and involved fewer women became pregnant after UAE the use of permanent embolic material. (OR, 0.29; 95% CI, 0.10–0.85). Among the findings: • Costs were lower with UAE, as assessed Bleeding outcomes were not by measuring the duration of the proce- measured Compared with dure, length of hospitalization, and time to Strengths of this systematic review are its hysterectomy and resumption of normal activities. inclusion of high-quality, randomized, con- myomectomy, UAE • Ovarian-failure rates were comparable trolled trials and its assessment of ovarian- costs were lower between women in the UAE and surgery failure rates. However, a major weakness is and postprocedure groups. Ovarian function was assessed by the fact that its design does not allow for dis- ovarian-failure rates measuring follicle-stimulating hormone crete evaluation of bleeding outcomes. Nor (FSH), although FSH thresholds varied in can its findings be broken down by the type were comparable some of the studies. of leiomyoma being treated. AUB-A: For adenomyosis-associated AUB, consider the LNG-IUS as an alternative to hysterectomy Ozdegirmenci O, Kayikcioglu F, Akgul MA, et al. Com- n a small randomized, controlled trial of the parison of levonorgestrel intrauterine system versus Ilevonorgestrel-releasing intrauterine sys- hysterectomy on efficacy and quality of life in patients tem (LNG-IUS; Mirena) versus hysterectomy with adenomyosis. Fertil Steril. 2011;95(2):497–502. for adenomyosis-associated AUB, women allocated to the LNG-IUS experienced a CONTINUED ON PAGE 30 28 OBG Management | March 2014 | Vol. 26 No. 3 obgmanagement.com UPDATE abnormal uterine bleeding CONTINUED FROM PAGE 28 reduction in bleeding and comparable gains WHAT THIS EVIDENCE MEANS FOR PRACTICE in hemoglobin values during the first year The relationship of adenomyosis to gynecologic symptoms, including of use. Both the LNG-IUS and hysterectomy heavy menstrual bleeding and dysmenorrhea, needs further study. improved health-related quality of life, but However, this trial confirmed that transvaginal ultrasound is helpful the LNG-IUS was associated with superior in the nonsurgical diagnosis of adenomyosis and suggests that the improvements in measures of psychological LNG-IUS may be as effective at 1 year as hysterectomy for the treat- and social functioning. ment of adenomyosis-associated heavy menstrual bleeding (AUB-A). Clinicians who perform office-based ultrasound to assess AUB Details and general findings of should familiarize themselves with the criteria for ultrasonic diagno- the trial sis of adenomyosis. These criteria include the presence of hetero- Eighty-six women were enrolled in the trial geneous myometrial echogenicity, a loss of clarity of the endo- after exclusion of endometrial pathology as myometrial interface, typically radially oriented linear striations, the a cause of their heavy menstrual bleeding appearance of myometrial cysts, and an overall globular enlarged and after transvaginal ultrasound and mag- uterus characterized by asymmetric thickening of the myometrium.2 In patients with heavy menstrual bleeding who have these find- netic resonance imaging findings were con- ings, particularly if there is coexistent dysmenorrhea and uterine sistent with the diagnosis of adenomyosis. tenderness, it behooves the clinician to consider the LNG-IUS as Participants then were randomly assigned first-line therapy, especially for women who wish to preserve fertil- to undergo hysterectomy or insertion of an ity, but also for women for whom fertility is not an issue. LNG-IUS (43 women in each group). At base- There is some evidence that the therapeutic effect of the line, the mean (SD) age was 44.28 (4.36) years LNG-IUS containing 20 µg of levonorgestrel may start to fade at 2 among women in the LNG-IUS group versus 3 or 3 years, a possibility that should be shared with patients. Other 46.38 (3.76) years among women undergoing features, such as cavity size, thickness of the myometrium, and the hysterectomy (P = .032), a statistical differ- coexistence of clinically relevant leiomyomas, have not been evalu- ence that I suspect is not clinically significant. ated but may have an impact on the clinical response. Menstrual bleeding, hemoglobin lev- els, and quality of life were assessed prior Have you heard this recent interview with the expert? Hear Dr. K. Anthony Shibley* expand on a novel strategy he has developed to address the problem of tissue dispersion during open power morcellation Also, view a 6-minute video of Dr. Shibley demonstrating his surgical technique of enclosed morcellation using a large bowel isolation bag. This illustrated technique is his short-term surgical solution to reducing the risk of uncontained morcellation until his device is available on the market. *From Obstetrics and Gynecology Specialists, Fairview Health Services, Minneapolis, Minnesota Find this and more expert interviews in the Audio Library at obgmanagement.com 30 OBG Management | March 2014 | Vol. 26 No. 3 obgmanagement.com to insertion or surgery, and again at 6- and myosis, six women (18.8%) had myomas, 12-month follow-up. Eleven women in the three women (9.4%) had both adenomyo- hysterectomy group were lost to follow-up. sis and a myoma, and two women (6.2%) General findings of the trial include: had a normal uterus. Serum hemoglobin • Women in the LNG-IUS group had a levels increased from a median of roughly mean reduction in the volume of men- 10.5 g/dL at the time of treatment to strual bleeding—as measured by the num- 13 g/dL at 6 months and slightly higher at ber of pads used—from two pads to one 12 months. (There were no statistically sig- pad at 6 months, remaining at that level nificant differences in hemoglobin values until 12 months. Serum hemoglobin lev- between the LNG-IUS and hysterectomy els increased from a median of just over groups at any point in the study.) Quality of 11 g/dL at the time of insertion to 13 g/dL at life improved in three of the five domains 6 months and slightly higher at 12 months. In assessed (physical and both environmental the five self-reported quality-of-life domains domains). assessed (physical, psychological, social, Although 11 women were lost to fol- environmental, and a national environmen- low-up, this trial appeared to have an ade- tal domain), women using the LNG-IUS quate sample size to examine the selected demonstrated improvement in all five.
Recommended publications
  • Heavy Menstrual Bleeding
    25/06/2018 Definition • Heavy menstrual bleeding (HMB) is defined as excessive menstrual blood loss which interferes with a woman's physical, social, emotional and/or material quality of life. Heavy Menstrual Bleeding (HMB): Replaced ‘menorrhagia’ Objective definition of HMB >80mL/ cycle or duration of >7 days Causes and Management • It can occur alone or in combination with other symptoms (e.g. intermenstrual bleeding, pelvic pain, pressure symptoms) Dr. William (Wee-Liak) Hoo, MD MRCOG Consultant Gynaecologist Prevalence King’s College Hospital NHS FT • The prevalence of HMB in objective studies (9 to 14%) and subjective studies 20 to 52%) in studies based on subjective assessment. • In the UK, almost 1.5 million women consult their General Practitioners UKCPA Women’s Health Group Masterclass (GPs) each year with menstrual complaints and the annual treatment cost Friday 22nd June 2018 exceeds £65 million. Causes • Uterine: Uterine fibroids (dysmenorrhoea, palpable mass, pressure symptoms) Adenomyosis (dysmenorrhoea, subfertility) Endometrial polyps (intermenstrual bleeding) Pelvic inflammatory disease (PID)/ infection (vaginal discharge, pelvic pain, intermenstrual and postcoital bleeding and pyrexia) Malignancy or atypical hyperplasia (irregular/ postcoital/ intermenstrual bleeding, pelvic pain, weight loss). • Ovarian: Polycystic ovary syndrome (acne, hursuitism) • Systemic diseases: Hypothyroidism (fatigue, constipation, cold intolerance and hair and skin changes) Coagulation disorders (e.g. von Willebrand disease) Liver
    [Show full text]
  • Management of Adenomyosis a Review of Characteristic Imaging Findings and Treatment Options, with an Emphasis on the Use of Uterine Artery Embolization
    WOMEN’S HEALTH Management of Adenomyosis A review of characteristic imaging findings and treatment options, with an emphasis on the use of uterine artery embolization. BY THERESA M. CARIDI, MD, AND JAMES B. SPIES, MD, MPH denomyosis is defined as ectopic endometrial tis- myosis on MRI include thickening of the junctional sue within the musculature of the uterus.1 It is a zone exceeding 12 mm and high-signal-intensity foci challenging condition in that it often overlaps in on T2/T1-weighted images similar to the case shown in symptoms and is found in conjunction with other Figure 1.4 Many studies have evaluated the diagnostic Agynecologic disorders, including endometriosis and uterine accuracy of TVUS and MRI techniques for adenomyosis. leiomyoma (fibroids).2 The typical clinical manifestations TVUS has a sensitivity of approximately 72% and speci- of adenomyosis occur in women who are 40 to 50 years of ficity of 81% versus 77% and 89% for MRI, respectively.8 age and include abnormal uterine bleeding and dysmenor- In addition, MRI can provide greater detail about the rhea (65% of patients).1 The exact pathogenesis is not fully extent of disease and additional uterine lesions, as well defined but is thought to be the result of direct invagina- as information about the less common presentation of tion of the endometrium into the myometrium.3 The adenomyosis, where focal disease in the form of an ade- interventionalist’s role is to offer uterine artery emboliza- nomyoma is present rather than the more typical diffuse tion (UAE), which provides some benefits over traditional adenomyosis findings.
    [Show full text]
  • Sonography of Adenomyosis
    3105jumonline.qxp:Layout 1 4/19/12 9:48 AM Page 805 SOUND JUDGMENT SERIES Sonography of Adenomyosis Khaled Sakhel, MD, Alfred Abuhamad, MD Invited paper denomyosis was first described by Rokitansky in 1860 as “cystosarcoma adenoides uterinum” and was later defined A by Von Recklinghausen in 1896. It is a common condition that predominantly affects women in the late reproductive years. Adenomyosis has been noted to occur in about 30% of the general female population and in up to 70% of hysterectomy specimens depending on the definition of the entity.1 The diagnosis can be The Sound Judgment Series consists of made with sonography or magnetic resonance imaging (MRI), but invited articles highlighting the clinical this article will show that sonography should be the imaging modal- value of using ultrasound first in specific ity of choice for adenomyosis. clinical diagnoses where ultrasound has Definition shown comparative or superior value. The series is meant to serve as an educational Adenomyosis is defined by the presence of ectopic endometrial tool for medical and sonography students glands and stroma within the myometrium. The presence of ectopic and clinical practitioners and may help endometrial glands and stroma induces a hypertrophic and hyper- integrate ultrasound into clinical practice. plastic reaction in the surrounding myometrial tissue. Clinical Presentation Most patients with adenomyosis are asymptomatic. Symptoms related to adenomyosis include dysmenorrhea, dyspareunia, chronic pelvic pain, and menstrual menometrorrhagia. Adeno- myosis presents most commonly as a diffuse disease involving the entire myometrium (Figure 1). It can also present in a focal area of the uterus, known as adenomyoma (Figure 2).
    [Show full text]
  • Chronic Vulvar Irritation, Itching, and Pain. What Is the Diagnosis?
    SECOND OF 2 PARTS ON OFFICE MANAGEMENT OF BENIGN VULVAR CONDITIONS Chronic vulvar irritation, itching, and pain. What is the diagnosis? Five cases of dermatoses, vaginal abnormalities, and pain syndromes that may masquerade as infection Libby Edwards, MD, and Beth E. Goldbaum, MD hronic irritation, itching, and pain CASE 1 Introital burning and a fear are only rarely due to infection. of breast cancer C These symptoms are more likely to A 56-year-old woman visits your office for be caused by dermatoses, vaginal abnormali- management of recent-onset introital burn- ties, and pain syndromes that may be difficult ing during sexual activity. She reports that to diagnose. Careful evaluation should in- her commercial lubricant causes irritation. clude a wet mount and culture to eliminate Topical and oral antifungal therapies have not infection as a cause so that the correct diag- been beneficial. She has a strong family his- IN THIS nosis can be ascertained and treated. tory of breast cancer. ARTICLE In Part 2 of this two-part series, we focus On examination, she exhibits small, When a woman on five cases of vulvar dermatologic disrup- smooth labia minora and experiences pain is reluctant to use tions: when a cotton swab is pressed against the local estrogen • atrophic vagina vestibule. The vagina is also smooth, with page 32 • irritant and allergic contact dermatitis scant secretions. Microscopically, these • complex vulvar aphthosis secretions are almost acellular, with no • desquamative inflammatory vaginitis increase in white blood cells and no clue A teenager • inverse psoriasis. cells, yeast forms, or lactobacilli. The pH is with vulvar pain greater than 6.5, and most epithelial cells are and sores parabasal (FIGURE 1, page 32).
    [Show full text]
  • Managing Infertility When Adenomyosis and Endometriosis Co-Exist
    Managing infertility when adenomyosis and endometriosis co-exist Jinhua Leng Beijing,China 27th April 2018 • IPSEN symposium Endometriosis • Endometriosis (EM) is a common, benign, ovary hormone-dependent gynecologic disorder which affects mainly reproductive-age women • Endometriosis is considered to be responsible for infertility and pelvic pain • May affect 10% of women of reproductive age • Three types of pelvic endometriosis • Peritoneal Endometriosis • Ovarian Endometrioma • Deeply Infiltrating Endometriosis (DIE) 27th April 2018 • IPSEN symposium Adenomyosis • Adenomyosis (AD) is defined by the presence of endometrial glands and stroma in the myometrium • Prevalence: varies significantly between studies (from 5% to 70%), generally underestimated • Most frequent symptoms: dysmenorrhea, abnormal uterine bleeding, etc. • Two types: diffuse form, focal form 27th April 2018 • IPSEN symposium PEM DIE OEM AD+EM 27th April 2018 • IPSEN symposium Macroscopic and microscopic appearance of AD 27th April 2018 • IPSEN symposium MRI Features of AD—focal and diffuse 27th April 2018 • IPSEN symposium Prevalence of EM in patients with AD Adenomyosis Endometriosis Author N N(%) Leng JH et al.(2011) 72(histology) 24(33.3%) Di Donato et al. (2014) 217(ultrasound) 165(76.0%) Chapron et al. (2017) 175(MRI) 153(87.4%) Leyendecker et al. (2015) 67(MRI) 54(80.6%) Em and AD often coexist Several authors reported the prevalence of EM in patients with AD. Our study showed in 72 histologically diagnosed AD, 33.3% had concomitant EM. Chapron and another 2 authors reported in US/MRI diagnosed AD, 76-87% had coexistant EM 27th April 2018 • IPSEN symposium What is the relationship between endometriosis phenotypes and adenomyosis? EM subtype N Diffuse form Focal form PEM 40 8(20.0%) 3(7.5%) OEM 31 14(45.2%) 6(19.3%) DIE 166 59(35.5%) 110(66.3%) • Surgery findings of 175 preoperatively MRI diagnosed AD and histologically diagnosed of EM • Among EM women, diffuse AD had no correlation with EM phenotypes.
    [Show full text]
  • Adenomyosis and Infertility
    Reproductive BioMedicine Online (2012) 24,35– 46 www.sciencedirect.com www.rbmonline.com REVIEW Adenomyosis and infertility Sebastiano Campo a, Vincenzo Campo a,*, Giuseppe Benagiano b a Institute of Obstetrics and Gynaecology, Catholic University of Sacred Heart, Rome, Italy; b Department of Obstetrics, Gynaecology and Urology, Sapienza, University of Rome, Rome, Italy * Corresponding author. E-mail address: [email protected] (V Campo). Prof Sebastiano Campo has been associate professor in the Department of Obstetrics and Gynecology at the Catholic University of the Sacred Heart in Rome since 1984. His special interests include ovarian physiology, infertility, endometriosis and polycystic ovary syndrome. Abstract Today an accurate diagnosis of adenomyosis can be made thanks to progress in imaging techniques: sonography and mag- netic resonance imaging (MRI). This has made it possible to clinically correlate the presence of adenomyosis to infertility. At the same time, a series of pathogenetic hypotheses have been presented to explain this correlation. First, the identification of the myo- metrial junctional zone (JZ) and of its disruption and thickening has been linked to poor reproductive performance mainly through perturbed uterine peristalsis, a phenomenon that originates exclusively from the JZ in the nonpregnant uterus. In addition, a number of biochemical and functional alterations in both eutopic and heterotopic endometrium in women with adenomyosis have now been found to lead to lower receptivity, indicated by the presence of ‘implantation marker’ defects. In these patients there is also an altered decidualization and abnormal concentrations of intrauterine free radicals. All these abnormalities in the endometrial envi- ronment seem to contribute to subfertility. Several attempts have been made to restore fertility in adenomyosis patients, the oldest being gonadotrophin-releasing hormone agonists coupled to conservative surgery.
    [Show full text]
  • Choose to Be Informed About Chronic Pelvic Pain Conditions
    Choose to Be Informed About ChronicPreparing Pelvic Painfor SurgeryConditions | | 3 1 Choose to Be Informed About Chronic Pelvic Pain Conditions. Pelvic Pain Conditions 2 Women’s Services at Every Age and Stage of Life 5 Screenings You Need 6 – 7 Your Medical History 8 – 10 Family History 11 – 12 My Physicians 13 Choose to Be Informed About ChronicPreparing Pelvic Painfor SurgeryConditions | | 3 2 Gynecological issues involving the pelvic area affect many women during their lifetime. Chronic pelvic pain is pain located between the stomach and hips that lasts for six months or longer. For women, there can be many different causes of pelvic pain. This guide explains the most common types of female pelvic conditions and what can be done to treat them. Abnormal Uterine Bleeding Painful Periods Abnormal uterine bleeding is defined as bleeding that Painful menstrual periods, also called dysmenorrhea, occurs between periods, or is heavier or lasts longer are the leading cause of lost time from school and than normal. Menstrual cycles that are longer than 35 work among women in their teens and 20s. Painful days or shorter than 21 days are considered abnormal. periods may include pain in the pelvis, abdomen, Bleeding that occurs after intercourse or any time after back and legs; abdominal cramps; headache; and menopause is also abnormal. fatigue. There are many possible causes of abnormal uterine There are two types of dysmenorrhea. Primary bleeding, including fibroids, polyps, infection dysmenorrhea is caused by high levels of or cancer of the uterus or cervix, polycystic prostaglandins — hormone-like substances — in the ovary syndrome (an endocrine system disorder), uterus.
    [Show full text]
  • Pregnancy Outcomes of Infertile Women with Co- Existing Endometriosis and Adenomyosis After Laparoscopic Surgery: a Long-Term Follow-Up
    Pregnancy outcomes of infertile women with co- existing endometriosis and adenomyosis after laparoscopic surgery: a long-term follow-up Jinghua Shi Peking Union Medical College Hospital https://orcid.org/0000-0001-5267-9092 Yi Dai Peking Union Medical College Hospital Junji Zhang Peking Union Medical College Hospital Xiaoyan Li Peking Union Medical College Hospital Shuangzhen Jia Peking Union Medical College Hospital Jinhua Leng ( [email protected] ) Peking Union Medical College Hospital Research article Keywords: Adenomyosis, Endometriosis; Infertility, Laparoscopic surgery, Pregnancy outcome Posted Date: October 6th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-85435/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/13 Abstract Background: Adenomyosis and endometriosis are often co-existent. Laparoscopic surgery is one of the main methods to diagnose and treat these conditions. However, very few studies have been done that concentrate on the pregnancy outcomes of infertile women with both adenomyosis and endometriosis after laparoscopic surgery, as well as the relevant inuential factors. Methods: This is a retrospective, cross-sectional study including infertile women diagnosed with endometriosis and adenomyosis. All patients had undergone laparoscopic surgery and were divided into two groups according to pregnancy outcomes. Demographic data, operation records, and pregnancy outcomes were collected. Results: Ninety-seven patients had live births, including 81 full-term and 16 preterm deliveries. The biochemical pregnancy, clinical pregnancy, and live birth rates were 80.87%, 67.4, and 55.11% respectively. One hundred thirty-ve patients received IVF with 70 (51.85%) patients having live births.
    [Show full text]
  • ACR Appropriateness Criteria: Abnormal Uterine Bleeding
    Revised 2020 American College of Radiology ACR Appropriateness Criteria® Abnormal Uterine Bleeding Variant 1: Abnormal uterine bleeding. Initial imaging. Procedure Appropriateness Category Relative Radiation Level US duplex Doppler pelvis Usually Appropriate O US pelvis transabdominal Usually Appropriate O US pelvis transvaginal Usually Appropriate O US sonohysterography May Be Appropriate (Disagreement) O MRI pelvis without and with IV contrast Usually Not Appropriate O MRI pelvis without IV contrast Usually Not Appropriate O CT pelvis with IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without and with IV contrast Usually Not Appropriate ☢☢☢☢ Variant 2: Abnormal uterine bleeding. Follow-up imaging when original ultrasound is inconclusive or further imaging characterization is needed. Procedure Appropriateness Category Relative Radiation Level US sonohysterography Usually Appropriate O MRI pelvis without and with IV contrast Usually Appropriate O US duplex Doppler pelvis May Be Appropriate (Disagreement) O US pelvis transabdominal May Be Appropriate (Disagreement) O US pelvis transvaginal May Be Appropriate (Disagreement) O MRI pelvis without IV contrast May Be Appropriate (Disagreement) O CT pelvis with IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without IV contrast Usually Not Appropriate ☢☢☢ CT pelvis without and with IV contrast Usually Not Appropriate ☢☢☢☢ ACR Appropriateness Criteria® 1 Abnormal Uterine Bleeding Variant 3: Abnormal uterine bleeding. Follow-up imaging
    [Show full text]
  • Dyspareunia: 5 Overlooked Causes
    OBGMANAGEMENT ■ BY ELIZABETH G. STEWART, MD Dyspareunia: 5 overlooked causes Disorders ranging from a simple anatomic problem to a complex psychosocial/ biologic phenomenon can cause difficult or painful coitus. An expert outlines diagnosis and treatment strategies for 5 common causes and offers guidance on how to conduct the physical exam and elicit information from the patient. dentifying the cause of a patient’s dyspare- pareunia can present a significant challenge unia can be just as challenging as getting to clinicians. Adding to the difficulty is the I her to admit to the problem. fact that intermittent conditions such as cycli- Due in part to underreporting of the con- cal Candida albicans are hard to diagnose. dition, the incidence and prevalence of dys- This review of 5 common but often over- pareunia—defined as genital pain experi- looked causes describes what is known about enced just before, during, or after sexual inter- dyspareunia and how to conduct a complete course1—is uncertain.2 evaluation, including physical examination, Because it is easy to miss subtle physical diagnostic tests, and questions to ask the patient. findings such as small fissures, periclitoral scarring, or a focus of tender vestibulitis under ■ CAUSE 1 a hymenal remnant, getting to the root of dys- Inadequate estrogenization Vulvovaginal atrophy is the leading cause of KEY POINTS sexual dysfunction, affecting up to 50% of ■ The leading cause of dyspareunia for women women over age 50. It contributes to a lack of under age 50 is vulvar vestibulitis; for women over vaginal lubrication with sexual arousal and, age 50, it is vulvovaginal atrophy.
    [Show full text]
  • National Institute for Health and Care Excellence
    IP 1065 [IPGXXX] NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of uterine artery embolisation for treating adenomyosis Treating adenomyosis by blocking the blood supply to affected parts of the uterus Adenomyosis is a condition where some of the lining tissue of the womb grows into its outer muscular layer: this can cause heavy and painful menstrual periods. Uterine artery embolisation involves injecting small particles into the blood vessels that take blood to the uterus, via arteries in the groin. The aim is to block the blood supply to the adenomyosis so that it shrinks, which may then relieve the symptoms. Introduction The National Institute for Health and Care Excellence (NICE) has prepared this overview to help members of the Interventional Procedures Advisory Committee (IPAC) make recommendations about the safety and efficacy of an interventional procedure. It is based on a rapid review of the medical literature and specialist opinion. It should not be regarded as a definitive assessment of the procedure. Date prepared This overview was prepared in April 2013. Procedure name Uterine artery embolisation for treating adenomyosis Specialist societies British Society of Interventional Radiology Royal College of Obstetricians and Gynaecologists Royal College of Radiologists IP overview: uterine artery embolisation for treating adenomyosis Page 1 of 33 IP 1065 [IPGXXX] Description Indications and current treatment Adenomyosis is a benign condition characterised by presence of ectopic endometrial glands and stroma within the myometrium. Adenomyosis frequently occurs coincidentally with fibroids. Adenomyosis may cause no symptoms but some women with adenomyosis experience heavy, prolonged menstrual bleeding with severe cramps, pelvic pain and discomfort.
    [Show full text]
  • Heavy Menstrual Bleeding
    Heavy Menstrual Bleeding Normal Periods A woman normally loses between 30 and 40ml of blood with her period (six to eight teaspoonfuls) each month but there is much variability. Bleeding can last up to eight days, but bleeding for five days is average. Heavy Menstrual Bleeding There are medical definitions of heavy menstrual bleeding, but the only practical definition is when there is excessive menstrual blood loss that interferes with the physical, emotional, social and material quality of life. Monthly periods are an individual experience and women who have always had heavy periods will consider this normal. However if you believe that your periods are either unusually heavy, prolonged or both, there are many different Figure 1. Female reproductive anatomy treatment options available to you. You may or may not have some of Uterine-related problems the following problems: 1. The uterus can have abnormalities in the muscle of the uterus wall that prevents the uterus from squeezing and contracting • Losing more than 5– 6 tablespoons of blood (80mls) well and hence allow blood vessels to continue to bleed • Passing clots that are larger than a 50 cent coin • Bleeding so much that you have to change your pad/tampon 2. Fibroids are benign non-cancerous growths in the muscle every hour of the uterus. Fibroids can cause heavy menstrual bleeding, • Having to get up most nights to change your pad/tampon pelvic pressure or pain and problems with fertility and • Having to put a towel in your bed or use large maternity pads pregnancy. However, fibroid symptoms tend to get better when you sleep after menopause.
    [Show full text]